Literature DB >> 7796884

Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor.

T Sekiguchi1, T Nakashima, T Hayashida, A Kuraoka, S Hashimoto, N Tsuchida, Y Shibata, T Hunter, T Nishimoto.   

Abstract

A temperature-sensitive (ts) mutant of the BHK21 cell line derived from golden hamsters, tsBN462 has a mutation in the gene encoding the largest subunit of the TFIID complex, TAFII250/p230/CCG1, and arrests in the G1 phase at the nonpermissive temperature, 39.5 degrees C. We found that tsBN462 cells underwent apoptosis following growth arrest at 39.5 degrees C, suggesting a role for CCG1 as a repressor of apoptosis. By electron microscopic observation, tsBN462 cells at 39.5 degrees C showed characteristic features of apoptosis. Apoptosis was not suppressed by expression of Bc1-2 or the adenovirus E1B 19 kDa protein. Cell death was suppressed completely by expression of wild-type CCG1 and partially by wild-type p53, a growth suppressor protein. Cell cycle arrest induced by p53 may help survival of tsBN462 cells at 39.5 degrees C. Apoptosis was accelerated in SV40 large T antigen-transformed tsBN462 cells at 39.5 degrees C where SV40 large T antigen formed a complex with p53, implying that the apoptosis of tsBN462 cells at 39.5 degrees C occurred in a p53-independent manner. Our results suggest that CCG1/TAFII250 is required for the expression of factors regulating apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796884     DOI: 10.1006/excr.1995.1183

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  TAF250 is required for multiple developmental events in Drosophila.

Authors:  D A Wassarman; N Aoyagi; L A Pile; E M Schlag
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.

Authors:  I Haviv; Y Matza; Y Shaul
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

3.  Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt.

Authors:  Yongjun Yu; James C Alwine
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes.

Authors:  T O'Brien; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Taf1 regulates Pax3 protein by monoubiquitination in skeletal muscle progenitors.

Authors:  Stéphane C Boutet; Stefano Biressi; Kevin Iori; Vanita Natu; Thomas A Rando
Journal:  Mol Cell       Date:  2010-12-10       Impact factor: 17.970

7.  Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells.

Authors:  D M Lukac; J C Alwine
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9.

Authors:  Mattia Frontini; Evi Soutoglou; Manuela Argentini; Christine Bole-Feysot; Bernard Jost; Elisabeth Scheer; Làszlò Tora
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

9.  Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.

Authors:  Xin Cai; Xuan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

10.  Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250.

Authors:  J L Siegert; P D Robbins
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.